... ...

One Decade, over 150 Successful Collaborations

A Project with Selventa

Discovery

Target Discovery

High Quality Proprietary Targets and IP

Drug Target

Lead Discovery

Drug Target

Lead Optimization

Drug Target

Development

Pre-Clinical

Efficacy and Safety Models with clinical relevance

Drug Candidate

Selventa leverages its technologies throughout the project timeline by developing optimized portfolios from proprietary patient data

Clinical Development

1

Phase I

Drug Candidate

2

Phase II

Patient Stratification and selection

Drug Candidate

3

Phase III

Drug Candidate

Approval Launch

Drug Candidate

Working with Us

Types of Collaborations:

  • Identify targets
  • Determine the major mechanisms causing a specific disease
  • Develop biomarkers that identify the patients with each mechanism
  • Understand how mechanisms differ across diseases
  • Identify biomarkers to create predictive diagnostic tests

Our technology and methodology have been applied across the the research & development continuum to answer a variety of specific scientific questions.

Collaboration

Selventa's services consist of proprietary analytics, internal biological expertise and a team of dedicated scientists whose focuses span both sides of the collaboration.

What to expect:

  • Clear goals and deliverables
  • Transparent communications:
    • weekly phone calls
    • twice-weekly email updates
    • web conferences three times monthly
    • quarterly on-site visits

Product

Selventa offers Software as a Service (SaaS) or usage-based licensing for it's cloud-based Development Platform (SDP).

The Selventa knowledgebase licensing (subscription) is a high quality, manually curated knowledgebase based on the OpenBEL Platform.

  • Knowledge from human, mouse and rat
  • Compiled from 50,000 publications and in excess of 600,000 causal statements
  • Captures detailed biological information to harness the current 'omics technologies (ex. SNPs, mutations, RNA/Proteins, activities, modifications)
learn more about the technology